Tonghua Dongbao Pharmaceutical Co. Ltd. | Ownership
Companies that own Tonghua Dongbao Pharmaceutical Co. Ltd.
China Universal Asset Management Co., Ltd.
129,738,260
6.58%
-67,942
2.81%
09/30/2017
Guotai Junan Allianz Fund Management Co., Ltd.
86,499,620
4.38%
16,245,706
13.77%
09/30/2017
AEGON-INDUSTRIAL Fund Management Co., Ltd.
46,766,117
2.37%
4,660,691
2.15%
09/30/2017
Fidelity Management & Research Co.
36,750,977
1.86%
5,606,703
0.01%
07/31/2018
Norges Bank Investment Management
30,133,013
1.53%
9,510,558
0.01%
09/30/2017
HuaAn Fund Management Co., Ltd.
18,733,072
0.95%
6,278,082
0.65%
12/31/2017
GF Fund Management Co., Ltd.
13,867,286
0.7%
-5,249,839
0.45%
12/31/2017
JF Asset Management Ltd.
13,611,292
0.69%
3,252,814
0.15%
06/30/2018
Zhong Ou Asset Management Co., Ltd
10,390,542
0.53%
2,374,725
0.49%
12/31/2017
Fidelity Management & Research (Hong Kong) Ltd.
10,083,098
0.51%
-107,795
0.6%
07/31/2018
| Address |
Dongbao New Village
Tonghua Jilin 134123
China
|
|
Employees
|
- |
| Website |
- |
| Updated |
07/08/2019 |
| Tonghua Dongbao Pharmaceutical Co., Ltd. is engaged in the manufacture, distribution, research and development of pharmaceuticals. Its main products include hard capsules, tablets, granules, small volume injections, traditional Chinese medicine, active pharmaceutical ingredients (recombinant human insulin) and bio-engineering products. The company also produces building materials such as plastic steel windows. |
